Related Experiment Video
Updated: Jul 29, 2025

07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
11.9K
An Analysis of Successful Hit-to-Clinical Candidate Pairs
1Jnana Therapeutics, One Design Center Pl Suite 19-400, Boston, Massachusetts 02210, United States.
Journal of Medicinal Chemistry
|May 24, 2023
Summary
Drug discovery frequently uses known compounds for lead generation, followed by random screening. Successful candidates often retain a key pharmacophore despite structural divergence from initial hits.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Computational Chemistry
Background:
- Lead generation is crucial for identifying drug candidates.
- Understanding common lead generation strategies informs future drug discovery efforts.
- Previous studies highlighted known compounds as a primary source for clinical candidates.
Purpose of the Study:
- To identify the most frequent lead generation strategies for clinical candidates.
- To analyze structural similarity between hits and clinical candidates.
- To examine elemental composition trends in successful drug candidates.
Main Methods:
- Analysis of 156 clinical candidates published in the Journal of Medicinal Chemistry (2018-2021).
- Evaluation of lead generation strategies including known compounds, random screening, directed screening, fragment screening, DNA-encoded library screening (DEL), and virtual screening.
- Tanimoto-MCS similarity analysis and examination of elemental incorporation (O, N, F, Cl, S).
Main Results:
- Known compounds (59%) and random screening (21%) were the most frequent lead generation strategies.
- Clinical candidates often showed significant structural distance from initial hits but shared key pharmacophores.
- Analysis of elemental composition revealed specific trends in successful drug candidates.
Conclusions:
- Lead generation from known compounds and random screening remains dominant in drug discovery.
- Pharmacophore preservation is critical for successful hit-to-lead optimization.
- Further investigation into structural modifications and elemental incorporation can guide the development of clinical candidates.
Related Concept Videos
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Pharmacokinetic Models: Comparison and Selection Criterion
114
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
114
Targets for Drug Action: Overview
6.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.5K

